Can the relationship between doctors and drug companies ever be a healthy one?

PLoS Medicine

Volumn 6, Issue 7, 2009, Pages

  D'Arcy, Emma ^a   Moynihan, Ray ^b  

^a MyPHID Limited   (United Kingdom)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EDUCATION; CLINICAL PRACTICE; COOPERATION; DRUG INDUSTRY; ECONOMIC ASPECT; FUNDING; HUMAN RELATION; PHYSICIAN; PROFIT; SHORT SURVEY;

CONFLICT OF INTEREST; DRUG INDUSTRY; EDITORIAL POLICIES; ETHICS, MEDICAL; HUMANS; INTERPROFESSIONAL RELATIONS; PHYSICIANS;

EID: 68049117181     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000075     Document Type: Short Survey

References (13)

1. Angell M (2009) Relationships with the drug industry: Keep at arm's length. BMJ 338: b222.
2. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, et al. (2007) A national survey of physician-industry relationships. New Engl J Med 356: 1742-1750.
3. Carey B, Harris G (2008 July 12) Psychiatric group faces scrutiny over drug industry ties. The New York Times. Available: http://www.nytimes.com/2008/ 07/12/washington/12psych.html?hp. Accessed 15 June 2009.
4. Hopkins Tanne J (2009) Pfizer to disclose payments of $500 to healthcare prescribers. BMJ 338: b689. doi:10.1136/bmj.b689.
5. Wazana A (2000) Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA 283: 373-380.
6. Hager M, Russell S, Fletcher SW, eds (2008) Continuing education in the health professions: Improving healthcare through lifelong learning. Chairman's summary of the conference. The Josiah Macy, Jr. Foundation. Available: http://www.josiahmacyfoundation.org/documents/Macy-ContEd-1-7-08.pdf. Accessed 15 June 2009.
7. Moghimi Y (2006) The "PharmFree" campaign: Educating medical students about industry influence. PLoS Med 3: e30. doi:10.1371/journal.pmed. 0030030.
8. Godlee F (2009) Doctors, patients, and the drug industry. BMJ 338: b463.
9. Lexchin J, Bero LA, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 326: 1167-1170.
10. Moynihan R (2008) Key opinion leaders: Independent experts or drug representatives in disguise? BMJ 336: 1402-1403.
11. Moynihan R (2008) Doctors' education: The invisible influence of drug company sponsorship. BMJ 336: 416-417.
12. Association of Health Care Journalists (2004) Fundraising policy. Available: http://www.healthjournalism.org/center-fundraisingPolicy.php. Accessed 15 June 2009.
13. The PLoS Medicine Editors (2004) Prescription for a healthy journal. PLoS Med 1: e22. doi:10.1371/journal.pmed.0010022.